Brief: Cidara Therapeutics Q2 revenue USD 7.614 million
03/08/2023 21:08
Aug 3 (Reuters) - Cidara Therapeutics Q2 revenue USD 7.614 million. * Q2 pretax profit USD -12.208 million * Q2 operating income USD -12.831 million * Q2 operating expenses USD 20.445 million * Q2 net income USD -12.357 million * Q2 EPS USD -0.14
Recent news on Cidara Therapeutics
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Brief: Merck Seeks Up To $8 Billion In Us Bond Sale Tied To Cidara Deal - Bloomberg News
Merck rises after Wells Fargo upgrades stock to 'overweight'
Factbox: Major deals involving U.S. drugmakers and biotechs over the past decade